by kenjiro | May 28, 2026
Max Verhage Max holds a degree in Biomedical Sciences and a Master’s in Management & Entrepreneurship in the Health and Life Sciences. This combination gives him a strong foundation at the intersection of clinical research, market-oriented development, and...
by kenjiro | May 28, 2026
Patricia Baumgart Patricia has a biotechnology degree and Master’s in biomedical sciences, what really makes her valuable to Orfenix is her hands-on experience and regulatory expertise. With an interest in public health, Patricia started her career at start-ups...
by kenjiro | May 28, 2026
Bertjan Ziere Bertjan holds a PhD in BioPharmaceutical Sciences from Leiden University and has more than 25 years of experience in pharmaceutical development across small molecules, vaccines, recombinant proteins, and gene and cell therapies. For over 20 years he...
by Vincent Van der Wel | Oct 17, 2024
Ivo de Nooijer Ivo has a biopharmaceutical sciences, Dutch law, and medical history degree. He is completing his PhD thesis, which investigates negotiations in early-stage licensing in the Netherlands’ life sciences and health sector. Ivo has worked in an...
by Vincent Van der Wel | Oct 17, 2024
Vincent van der Wel Vincent holds degrees in Medicine, Business Studies, and Health Economics. This mix gives Vincent a good understanding of the clinical impact of treatments on clinicians and patients and the economic impact of drug development on payers,...
